Highlights from Stanford Drug Discovery Symposium 2021

Assessing physical activity and sleep patterns in glaucoma using wearable devices.

The British journal of ophthalmology·2026

RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.

European heart journal·2026

Damaging RBM20 E-rich domain variants are not rescued by gene replacement.

bioRxiv : the preprint server for biology·2026

Cross-cohort analysis of expression and splicing quantitative trait loci in TOPMed.

Science (New York, N.Y.)·2026

Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.

Circulation·2026

Genotype-Specific Electrophysiological Remodeling in PLN R14del Cardiomyopathy: Implications for Precision Antiarrhythmic Therapy.

Circulation. Arrhythmia and electrophysiology·2026

Free fatty acid receptor 4 in cardiac myocytes ameliorates ischemic cardiomyopathy.

Cardiovascular research·2026

Inflammatory cytokines and immune signalling in heart failure: mechanisms, models and emerging therapies.

Cardiovascular research·2026

Timing of food intake impacts cardiovascular and neuroendocrine physiology and risk of disease.

Cardiovascular research·2026

Dual inhibition of SGLT 1 and 2 by sotagliflozin alleviates intracellular sodium overload and improves cardiometabolic remodelling in uraemic cardiomyopathy.

Cardiovascular research·2026

Liver sinusoidal endothelial cell (LSEC) defenestration in chronic heart failure is primarily dependent on cardiac diastolic dysfunction and is reversed by sodium-glucose cotransporter 2 inhibitor but not by angiotensin-converting enzyme inhibitor.

Cardiovascular research·2026

Polycystin-1 suppresses apoptotic signalling in endothelial cells and protects from atherosclerosis.

Cardiovascular research·2026

Recent Developments and Structure-Activity Relationships of BRAF Inhibitors for Cancer Drug Discovery.

Archiv der Pharmazie·2026

Sequential soxhlet fractionation of Cistus ladanifer L. reveals a polarity-activity gradient: GC-MS profiling, multimechanistic bioactivity, and in silico identification of antifungal and antibacterial lead compounds.

Frontiers in chemistry·2026

Novel Benzofuran Derivatives as SARM1 Inhibitors for Treating Axonal Degeneration.

ACS medicinal chemistry letters·2026

Novel Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung Cancer.

ACS medicinal chemistry letters·2026

Structure-Activity Relationship Studies Resulting in the Identification of Potent and Selective Salt-Inducible Kinase Inhibitors.

ACS medicinal chemistry letters·2026

Structural Preferences and ADMET Regulation of Fluorinated Small-Molecule Drugs.

ACS medicinal chemistry letters·2026

Related Experiment Videos

Highlights from Stanford Drug Discovery Symposium 2021

Related Concept Videos

Assessing physical activity and sleep patterns in glaucoma using wearable devices.

RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.

Damaging RBM20 E-rich domain variants are not rescued by gene replacement.

Cross-cohort analysis of expression and splicing quantitative trait loci in TOPMed.

Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.

Genotype-Specific Electrophysiological Remodeling in PLN R14del Cardiomyopathy: Implications for Precision Antiarrhythmic Therapy.

Free fatty acid receptor 4 in cardiac myocytes ameliorates ischemic cardiomyopathy.

Inflammatory cytokines and immune signalling in heart failure: mechanisms, models and emerging therapies.

Timing of food intake impacts cardiovascular and neuroendocrine physiology and risk of disease.

Dual inhibition of SGLT 1 and 2 by sotagliflozin alleviates intracellular sodium overload and improves cardiometabolic remodelling in uraemic cardiomyopathy.

Liver sinusoidal endothelial cell (LSEC) defenestration in chronic heart failure is primarily dependent on cardiac diastolic dysfunction and is reversed by sodium-glucose cotransporter 2 inhibitor but not by angiotensin-converting enzyme inhibitor.

Polycystin-1 suppresses apoptotic signalling in endothelial cells and protects from atherosclerosis.

Recent Developments and Structure-Activity Relationships of BRAF Inhibitors for Cancer Drug Discovery.

Sequential soxhlet fractionation of Cistus ladanifer L. reveals a polarity-activity gradient: GC-MS profiling, multimechanistic bioactivity, and in silico identification of antifungal and antibacterial lead compounds.

Novel Benzofuran Derivatives as SARM1 Inhibitors for Treating Axonal Degeneration.

Novel Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung Cancer.

Structure-Activity Relationship Studies Resulting in the Identification of Potent and Selective Salt-Inducible Kinase Inhibitors.

Structural Preferences and ADMET Regulation of Fluorinated Small-Molecule Drugs.

Related Experiment Videos

Highlights from Stanford Drug Discovery Symposium 2021

Related Concept Videos

Related Articles